Statement Of Cash Flows [Abstract]

Sopharma AD - Filing #6139233

Concept 2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
99 874 BGN
3 897 BGN
95 977 BGN
95 977 BGN
71 121 BGN
76 333 BGN
71 121 BGN
5 212 BGN
Interest paid, classified as operating activities
10 147 BGN
5 921 BGN
Other inflows (outflows) of cash, classified as operating activities
2 889 BGN
1 457 BGN
Cash flows from (used in) operating activities
45 031 BGN
110 082 BGN
Cash flows from (used in) investing activities [abstract]
Other cash receipts from sales of equity or debt instruments of other entities, classified as investing activities
578,000 BGN
628,000 BGN
Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities
13 440 BGN
675,000 BGN
Proceeds from sales of property, plant and equipment, classified as investing activities
15 029 BGN
1 923 BGN
Purchase of property, plant and equipment, classified as investing activities
24 389 BGN
19 347 BGN
Purchase of intangible assets, classified as investing activities
18 897 BGN
4 309 BGN
Cash advances and loans made to other parties, classified as investing activities
4 696 BGN
1 962 BGN
Cash receipts from repayment of advances and loans made to other parties, classified as investing activities
- BGN
4,000 BGN
Dividends received, classified as investing activities
26,000 BGN
33,000 BGN
Interest received, classified as investing activities
3 442 BGN
965,000 BGN
Cash flows from (used in) investing activities
62 849 BGN
63 606 BGN
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
156 084 BGN
- BGN
Payments of lease liabilities, classified as financing activities
18 795 BGN
16 081 BGN
Proceeds from government grants, classified as financing activities
36,000 BGN
34,000 BGN
Dividends paid, classified as financing activities
71 889 BGN
11,000 BGN
Cash flows from (used in) financing activities
126 842 BGN
64 342 BGN
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
1 658 BGN
1 599 BGN
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
109 024 BGN
17 866 BGN
Cash and cash equivalents
128 879 BGN
19 855 BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.